2021, Number 2
<< Back Next >>
Rev Cubana Invest Bioméd 2021; 40 (2)
New advances and challenges in the use of convalescent plasma in patients with COVID-19
Auza-Santiváńez JC, Escobedo AA, Jaldín-Vasquez JP, Ávila HA
Language: Spanish
References: 7
Page: 1-3
PDF size: 139.56 Kb.
Text Extraction
No abstract.
REFERENCES
Rodríguez-Venegas Ed, Fontaine-Ortiz JE, Ávila-Cabreja JA. El plasma de convalecientes como un tratamiento potencial en pacientes con COVID-19. Rev Cubana Inv Bioméd. 2021[acceso: 23/02/2021]; 40(1). Disponible en: Disponible en: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/893
Subbarao K, Mordant F, Rudraraju R. Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience. Eur J Immunol. 2020;50:1447-53. DOI: 10.1002/eji.202048723
Joyner MJ, Bruno KA, Klassen SA, Kunze KL, Johnson PW, Lesser ER, et al. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clinic Proceedings. 2020;95(9):1888-97. DOI: 10.1016/J.MAYOCP.2020.06.028
Janiaud P, Axfors C, Schmitt AM, Gloy V, Ebrahimi F, Hepprich M, et al. Association of Convalescent Plasma Treatment with Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis. JAMA. 2021;325(12):1185-95. DOI: 10.1001/jama.2021.2747
Infectious Diseases Society of America. Clarifying the Emergency Use Authorization framework for COVID- convalescent plasma: considerations for clinicians prepared jointly by the Infectious Diseases Society of America and AABB. November 2020[acceso: 23/02/2021]. Disponible en: Disponible en: https://www.idsociety.org/globalassets/covid--real-timelearning-network/therapeutics-and-interventions/convalescent-plasma/aabb-idsa-convalescent-plasma-eua--nal.pdf
Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) BMJ 2020;371:m3939. DOI: 10.1136/bmj.m3939
RECOVERY. Recovery trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19. Statement from the RECOVERY trial chief investigators. 15/01/2021. Disponible en: https://www.recoverytrial.net/news/statement-from-the-recovery-trial-chief-investigators-15-january-2021-recovery-trial-closes-recruitment-to-convalescent-plasma-treatment-for-patients-hospitalised-with-covid-19
Full text